FIGO Stage IV and Age Over 55 Years as Prognostic Predicators in Patients With Metastatic Malignant Struma Ovarii

Introduction: Metastatic malignant struma ovarii (MSO) is an extremely rare disease that lacks treatment consensus and accurate prognosis. The objective of this study was to present the clinical, pathological, and treatment characteristics of metastatic MSO, while also investigate the overall surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Sijian, Yang, Tengyu, Li, Xiaoyan, Zhang, Limeng, Shi, Honghui, Cheng, Ninghai, Lang, Jinghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550973/
https://www.ncbi.nlm.nih.gov/pubmed/33117719
http://dx.doi.org/10.3389/fonc.2020.584917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550973/
https://www.ncbi.nlm.nih.gov/pubmed/33117719
http://dx.doi.org/10.3389/fonc.2020.584917

Ejemplares similares